On ECHEMI
Home > Drugs > Yili Pharmaceutical Co., Ltd.
Yili Pharmaceutical Co., Ltd.
  • Founded in:

    2008-12-26
  • Country:

    China China
  • Address:

    Fengshan Road, Dongcheng District, Sihui City
  • Tax NO.:

    914412006824906322
  • Registered Funds:

    100 million yuan
  • Website:

  • Email:

Related Drugs
Compound Acorus Calamus Basic Bismuth Nitrate Tablets
This product is a compound preparation, each tablet containing 175 mg of bismuth subnitrate, 200 mg of heavy magnesium carbonate, 100 mg of sodium bicarbonate, 12.5 mg of rhubarb powder, and 12.5 mg of calamus root powder.
Name Description Content CAS NO. Registered Holders
Bismuth subnitrate

Protect gastric mucosa, astringent, antidiarrheal effect

More

Protect gastric mucosa, astringent, antidiarrheal effect

175mg 1304-85-4 17
Magnesium carbonate

Neutralizes gastric acid, reduces the ability of pepsin to decompose gastric wall protein, weakens or eliminates the corrosive and irritating effects of gastric acid on the surface of gastrointestinal ulcers; magnesium ions have a mild laxative effect

More

Neutralizes gastric acid, reduces the ability of pepsin to decompose gastric wall protein, weakens or eliminates the corrosive and irritating effects of gastric acid on the surface of gastrointestinal ulcers; magnesium ions have a mild laxative effect

200mg 546-93-0 12
Sodium bicarbonate

Neutralize gastric acid, reduce the ability of pepsin to decompose gastric wall protein, and weaken or eliminate the corrosive and irritating effects of gastric acid on the surface of gastrointestinal ulcers

More

Neutralize gastric acid, reduce the ability of pepsin to decompose gastric wall protein, and weaken or eliminate the corrosive and irritating effects of gastric acid on the surface of gastrointestinal ulcers

100mg 144-55-8 45
RHUBARB FLUID EXTRACT

Eliminate constipation and enhance gastrointestinal digestive function

More

Eliminate constipation and enhance gastrointestinal digestive function

12.5mg 0
Acorus calamus root powder

Eliminate constipation and enhance gastrointestinal digestive function

More

Eliminate constipation and enhance gastrointestinal digestive function

12.5mg 0
Ganmaoling Granules
Trichosanthes, calendula, wild chrysanthemum, rhodiola rosea, caffeine, acetaminophen, chlorpheniramine maleate, peppermint oil. The auxiliary material is sucrose powder.
Name Description Content CAS NO. Registered Holders
Sanchaku

Not yet clear

More

Not yet clear

0
HERBA BIDENTIS

Not yet clear

More

Not yet clear

0
Chrysanthelandioum

Not yet clear

More

Not yet clear

0
Gangmei

Not yet clear

More

Not yet clear

0
Caffeine

Not yet clear

More

Not yet clear

0
Acetaminophen

Not yet clear

More

Not yet clear

103-90-2 68
Chlorphenamine maleate

Not yet clear

More

Not yet clear

113-92-8 28
Cornmint oil

Not yet clear

More

Not yet clear

68917-18-0 1
Sucrose powder

Not yet clear

More

Not yet clear

0
Rifampicin Capsules
The main ingredient of this product is rifampicin, and its chemical name is 3-[[(4-methyl-1-piperazinyl)imino]methyl]-rifamycin.
Name Description Content CAS NO. Registered Holders
Rifampicin

Rifampicin is a semi-synthetic broad-spectrum antibacterial drug of the rifamycin class, which has antibacterial activity against a variety of pathogenic microorganisms. The drug has a significant bactericidal effect on Mycobacterium tuberculosis and some non-tuberculous mycobacteria (including Mycobacterium leprae, etc.) both inside and outside the host cells. Rifampicin has a good antibacterial effect on aerobic Gram-positive bacteria, including enzyme-producing strains of Staphylococcus aureus and methicillin-resistant strains, Streptococcus pneumoniae, other Streptococcus, Enterococcus, Listeria, Bacillus anthracis, Clostridium perfringens, Corynebacterium diphtheriae, anaerobic cocci, etc. It also has a high degree of antibacterial activity against aerobic Gram-negative bacteria such as Neisseria meningitidis, Haemophilus influenzae, and Neisseria gonorrhoeae. Rifampicin also has a good effect on Legionella, and has an inhibitory effect on pathogens such as Chlamydia trachomatis, lymphogranuloma venereum, and psittacosis.

More

Rifampicin is a semi-synthetic broad-spectrum antibacterial drug of the rifamycin class, which has antibacterial activity against a variety of pathogenic microorganisms. The drug has a significant bactericidal effect on Mycobacterium tuberculosis and some non-tuberculous mycobacteria (including Mycobacterium leprae, etc.) both inside and outside the host cells. Rifampicin has a good antibacterial effect on aerobic Gram-positive bacteria, including enzyme-producing strains of Staphylococcus aureus and methicillin-resistant strains, Streptococcus pneumoniae, other Streptococcus, Enterococcus, Listeria, Bacillus anthracis, Clostridium perfringens, Corynebacterium diphtheriae, anaerobic cocci, etc. It also has a high degree of antibacterial activity against aerobic Gram-negative bacteria such as Neisseria meningitidis, Haemophilus influenzae, and Neisseria gonorrhoeae. Rifampicin also has a good effect on Legionella, and has an inhibitory effect on pathogens such as Chlamydia trachomatis, lymphogranuloma venereum, and psittacosis.

13292-46-1 24
Rifampicin Capsules
The main ingredient of this product is rifampicin, and its chemical name is 3-[[(4-methyl-1-piperazinyl)imino]methyl]-rifamycin.
Name Description Content CAS NO. Registered Holders
Rifampicin

Rifampicin is a semi-synthetic broad-spectrum antibacterial drug of the rifamycin class, which has antibacterial activity against a variety of pathogenic microorganisms. The drug has a significant bactericidal effect on Mycobacterium tuberculosis and some non-tuberculous mycobacteria (including Mycobacterium leprae, etc.) both inside and outside the host cells. Rifampicin has a good antibacterial effect on aerobic Gram-positive bacteria, including enzyme-producing strains of Staphylococcus aureus and methicillin-resistant strains, Streptococcus pneumoniae, other Streptococcus, Enterococcus, Listeria, Bacillus anthracis, Clostridium perfringens, Corynebacterium diphtheriae, anaerobic cocci, etc. It also has a high degree of antibacterial activity against aerobic Gram-negative bacteria such as Neisseria meningitidis, Haemophilus influenzae, and Neisseria gonorrhoeae. Rifampicin also has a good effect on Legionella, and has an inhibitory effect on pathogens such as Chlamydia trachomatis, lymphogranuloma venereum, and psittacosis.

More

Rifampicin is a semi-synthetic broad-spectrum antibacterial drug of the rifamycin class, which has antibacterial activity against a variety of pathogenic microorganisms. The drug has a significant bactericidal effect on Mycobacterium tuberculosis and some non-tuberculous mycobacteria (including Mycobacterium leprae, etc.) both inside and outside the host cells. Rifampicin has a good antibacterial effect on aerobic Gram-positive bacteria, including enzyme-producing strains of Staphylococcus aureus and methicillin-resistant strains, Streptococcus pneumoniae, other Streptococcus, Enterococcus, Listeria, Bacillus anthracis, Clostridium perfringens, Corynebacterium diphtheriae, anaerobic cocci, etc. It also has a high degree of antibacterial activity against aerobic Gram-negative bacteria such as Neisseria meningitidis, Haemophilus influenzae, and Neisseria gonorrhoeae. Rifampicin also has a good effect on Legionella, and has an inhibitory effect on pathogens such as Chlamydia trachomatis, lymphogranuloma venereum, and psittacosis.

13292-46-1 24
Rifampicin Capsules
The main ingredient of this product is rifampicin, and its chemical name is 3-[[(4-methyl-1-piperazinyl)imino]methyl]-rifamycin.
Name Description Content CAS NO. Registered Holders
Rifampicin

Rifampicin is a semi-synthetic broad-spectrum antibacterial drug of the rifamycin class, which has antibacterial activity against a variety of pathogenic microorganisms. The drug has a significant bactericidal effect on Mycobacterium tuberculosis and some non-tuberculous mycobacteria (including Mycobacterium leprae, etc.) both inside and outside the host cells. Rifampicin has a good antibacterial effect on aerobic Gram-positive bacteria, including enzyme-producing strains of Staphylococcus aureus and methicillin-resistant strains, Streptococcus pneumoniae, other Streptococcus, Enterococcus, Listeria, Bacillus anthracis, Clostridium perfringens, Corynebacterium diphtheriae, anaerobic cocci, etc. It also has a high degree of antibacterial activity against aerobic Gram-negative bacteria such as Neisseria meningitidis, Haemophilus influenzae, and Neisseria gonorrhoeae. Rifampicin also has a good effect on Legionella, and has an inhibitory effect on pathogens such as Chlamydia trachomatis, lymphogranuloma venereum, and psittacosis.

More

Rifampicin is a semi-synthetic broad-spectrum antibacterial drug of the rifamycin class, which has antibacterial activity against a variety of pathogenic microorganisms. The drug has a significant bactericidal effect on Mycobacterium tuberculosis and some non-tuberculous mycobacteria (including Mycobacterium leprae, etc.) both inside and outside the host cells. Rifampicin has a good antibacterial effect on aerobic Gram-positive bacteria, including enzyme-producing strains of Staphylococcus aureus and methicillin-resistant strains, Streptococcus pneumoniae, other Streptococcus, Enterococcus, Listeria, Bacillus anthracis, Clostridium perfringens, Corynebacterium diphtheriae, anaerobic cocci, etc. It also has a high degree of antibacterial activity against aerobic Gram-negative bacteria such as Neisseria meningitidis, Haemophilus influenzae, and Neisseria gonorrhoeae. Rifampicin also has a good effect on Legionella, and has an inhibitory effect on pathogens such as Chlamydia trachomatis, lymphogranuloma venereum, and psittacosis.

13292-46-1 24
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.